KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Depreciation & Amortization (CF) (2016 - 2026)

Thermo Fisher Scientific filings provide 18 years of Depreciation & Amortization (CF) readings, the most recent being $306.0 million for Q1 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 10.87% to $306.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $1.1 billion, a 5.75% decrease, with the full-year FY2025 number at $1.0 billion, down 9.17% from a year prior.
  • Depreciation & Amortization (CF) hit $306.0 million in Q1 2026 for Thermo Fisher Scientific, up from $292.0 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $306.0 million in Q1 2026 to a low of $227.0 million in Q3 2025.
  • Median Depreciation & Amortization (CF) over the past 5 years was $270.0 million (2023), compared with a mean of $268.6 million.
  • Biggest five-year swings in Depreciation & Amortization (CF): rose 26.26% in 2022 and later dropped 21.99% in 2025.
  • Thermo Fisher Scientific's Depreciation & Amortization (CF) stood at $256.0 million in 2022, then grew by 7.81% to $276.0 million in 2023, then grew by 10.14% to $304.0 million in 2024, then fell by 3.95% to $292.0 million in 2025, then grew by 4.79% to $306.0 million in 2026.
  • The last three reported values for Depreciation & Amortization (CF) were $306.0 million (Q1 2026), $292.0 million (Q4 2025), and $227.0 million (Q3 2025) per Business Quant data.